StonvexLoading…
StonvexStonvexStonvexCore line items from TEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.42B | $5.13B | $5.15B | $4.42B |
Operating Income | $475.00M | $526.00M | $637.00M | $420.00M |
Net Income | $221.00M | $335.00M | $518.00M | $300.00M |
EPS (Diluted) | $3.33 | $4.96 | $7.58 | $4.32 |
Total Assets | $6.14B | $5.73B | $3.62B | $3.12B |
Total Liabilities | $4.04B | $3.90B | $1.94B | $1.94B |
Cash & Equivalents | $772.00M | $388.00M | $371.00M | $304.10M |
Free Cash Flow OCF − CapEx | $322.00M | $189.00M | $332.00M | $151.00M |
Shares Outstanding | 66.30M | 67.60M | 68.30M | 69.40M |